Psyence Biomedical Ltd.
PBMHealthcare|Biotechnology|CA
$2.96
+0.02 (+0.68%)
DCF Value
$9.82
Tangible Book / Share
$30.68
Cash / Share
$13.48
Ownership Breakdown
100.0%
Float
0.0M
Shares Outstanding
0.0M
Float Shares
Major Holders (7)
Combined: 85.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Psyence Labs Ltd. | Corporation | 49.75% | 2,643,659 | Oct 15, 2026 | 13D/G |
| White Lion Capital, LLC | Other | 8.93% | 100,000 | Dec 13, 2024 | 13D/G |
| AdvisorShares Trust | Investment company | 6.78% | 258,538 | Oct 5, 2026 | 13D/G |
| Sander Gerber | HC, IN | 4.99% | 237,768 | May 14, 2025 | 13D/G |
| Hudson Bay Capital Management LP | IA, PN | 4.99% | 237,768 | May 14, 2025 | 13D/G |
| KAOS Capital Ltd. | IV, CO | 4.91% | 313,876 | Jan 13, 2026 | 13D/G |
| Adam Arviv | Individual | 4.91% | 313,876 | Jan 13, 2026 | 13D/G |